131 related articles for article (PubMed ID: 9466668)
1. Combination of cisplatin and radiation in cell culture: effect of duration of exposure to drug and timing of irradiation.
Gorodetsky R; Levy-Agababa F; Mou X; Vexler AM
Int J Cancer; 1998 Feb; 75(4):635-42. PubMed ID: 9466668
[TBL] [Abstract][Full Text] [Related]
2. Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines.
Gorodetsky R; Mou X; Pfeffer MR; Peretz T; Levy-Agababa F; Vexler AM
Isr J Med Sci; 1995; 31(2-3):95-100. PubMed ID: 7744601
[TBL] [Abstract][Full Text] [Related]
3. [Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer].
Scalliet P; De Pooter C; Hellemans PW; De Bruijn EA; Van Oosterom AT
Cancer Radiother; 1999; 3(1):30-8. PubMed ID: 10083861
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer.
Zhang X; Yang H; Gu K; Chen J; Rui M; Jiang GL
Int J Nanomedicine; 2011; 6():437-44. PubMed ID: 21499433
[TBL] [Abstract][Full Text] [Related]
5. Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.
De Pooter CM; Scalliet PG; Elst HJ; Huybrechts JJ; Gheuens EE; Van Oosterom AT; Fichtinger-Schepman AM; De Bruijn EA
Cancer Res; 1991 Sep; 51(17):4523-7. PubMed ID: 1873796
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment schedule on the interaction of Cisplatin and radiation in human lung cancer cells.
Asaka-Amano Y; Takiguchi Y; Yatomi M; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
Radiat Res; 2007 Jun; 167(6):637-44. PubMed ID: 17523845
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
8. Significance of scheduling on the cytotoxicity of radiation and cisplatin combination treatment in nasopharyngeal carcinoma cells.
Wang X; Chow LS; Nicholls JM; Kwong DL; Sham JS; Wong YC; Tsao SW
Anticancer Drugs; 2002 Oct; 13(9):957-64. PubMed ID: 12394259
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell line.
Kohara H; Tabata M; Kiura K; Ueoka H; Kawata K; Chikamori M; Aoe K; Chikamori K; Matsushita A; Harada M
Clin Cancer Res; 2002 Jan; 8(1):287-92. PubMed ID: 11801571
[TBL] [Abstract][Full Text] [Related]
10. Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results.
Lagrange JL; Fischel JL; Galliani S; Formento P; Guillot T; Bardon M; Milano G
Eur J Cancer; 1993; 29A(11):1531-5. PubMed ID: 8217357
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
Gorodetsky R; Levdansky L; Ringel I; Vexler A
Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation.
Gupta N; Hu LJ; Deen DF
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):885-95. PubMed ID: 9128966
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system.
Ning S; Yu N; Brown DM; Kanekal S; Knox SJ
Radiother Oncol; 1999 Feb; 50(2):215-23. PubMed ID: 10368046
[TBL] [Abstract][Full Text] [Related]
14. [Cross-resistance to radiation in human squamous cell carcinoma cells with induced cisplatin resistance].
Komori K
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):202-12. PubMed ID: 9711039
[TBL] [Abstract][Full Text] [Related]
15. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E
Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999
[TBL] [Abstract][Full Text] [Related]
16. Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
Herman TS; Teicher BA; Holden SA; Pfeffer MR; Jones SM
Cancer Res; 1990 May; 50(9):2734-40. PubMed ID: 2139359
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
[TBL] [Abstract][Full Text] [Related]
18. [Probability of the combination use of cisplatin and carboplatin].
Kobayashi K; Hino M; Hayashihara K; Niitani H
Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2684-92. PubMed ID: 2277219
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effect of cisplatin in combination with irradiation on lung tumor cell growth is due to induction of tumor cell apoptosis.
Fujita M; Fujita T; Kodama T; Tsuchida T; Higashino K
Int J Oncol; 2000 Aug; 17(2):393-7. PubMed ID: 10891552
[TBL] [Abstract][Full Text] [Related]
20. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
